DS
Douglas B. Snyder
Chief Legal Officer

Douglas B. Snyder insider trades: Gw Pharmaceuticals (GWPH) stock sales

Chief Legal Officer, Gw Pharmaceuticals Last trade Mar 26, 2021 20 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2019
2
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Douglas reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 26, 2021GWPH↓ Sell$152K
Dec 7, 2020GWPH↓ Sell$296K
Sep 30, 2020GWPH↓ Sell$117K
Aug 11, 2020GWPH↓ Sell$226K
Jul 6, 2020GWPH↓ Sell$103K
Mar 2, 2020GWPH↓ Sell$21K
Feb 26, 2020GWPH↓ Sell$36K
Aug 19, 2019GWPH↓ Sell$71K
Aug 12, 2019GWPH↓ Sell$52K
Jul 9, 2019GWPH↓ Sell$72K
Feb 26, 2019GWPH↓ Sell$58K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Douglas B. Snyder's insider trades

Douglas B. Snyder is Chief Legal Officer at Gw Pharmaceuticals (GWPH). Since Feb 26, 2019, Douglas has reported no open-market purchases and 11 sales worth $1.2M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (7 filings), option exercises (3 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GWPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.